Report Code: A03908 | Apr 2022 | Pages: 205 | ||
Tables: 180 | Charts: 67 |
|
The South africa global sepsis diagnostic market is analyzed on the basis of method, product, technology, usability, pathogen.
The report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry. These market players have been profiled in the report along with their strategic developments, such as partnership, expansion, collaboration, joint ventures, and others. The report also provides a detailed national market analysis on the basis of competitive scenario and how the competition will evolve in the coming years. The current market is also quantitatively analyzed to highlight the growth scenario of the market.
TOP IMPACTING FACTORS: MARKET SCENARIO ANALYSIS, TRENDS, DRIVERS, AND IMPACT ANALYSIS
The factors that are expected to drive/restrain the demand for South africa global sepsis diagnostic market are analyzed in the study. In addition, the cost impact on the market growth/decline has been thoroughly explained. Moreover, the potential factors are anticipated to provide lucrative opportunities for the market expansion. Furthermore, the detailed impact of the COVID-19 pandemic has been assessed on the growth/decline of the market.
COVID-19 IMPACT ANALYSIS
The outbreak of COVID-19 has radically affected most industry verticals across the globe. The report will cover the impact of COVID-19 on the South africa global sepsis diagnostic market, offering an explicit analysis of the scenario. It further provides the market strategies embraced by the major players during the pandemic. Moreover, the report encapsulates how COVID-19 has affected the supply chain. The market also states how the mass roll-out of vaccination is going to affect the South africa global sepsis diagnostic market in its post-COVID-19 impact analysis.
Â
Global Sepsis Diagnostic Market Report Highlights
Aspects | Details |
---|---|
Market Size By 2030 | USD 1.2 billion |
Growth Rate | CAGR of 7.8% |
Forecast period | 2020 - 2030 |
Report Pages | 205 |
By Technology |
|
By Method |
|
By Product |
|
By Usability |
|
By Pathogen |
|
By Region |
|
Key Market Players | BioMerieux SA, Danaher Corporation, Thermo Fisher Scientific Inc., Nanosphere, Inc., T2 Biosystems, Inc, CEPHEID INC., Becton, Dickinson and Company, Bruker Corporation, Abbott Laboratories, Inc., F. HOFFMANN-LA ROCHE AG |
Analyst Review
Â
This section provides various opinions of the top-level CXOs in the sepsis diagnostics market industry. In accordance with several interviews conducted, the utilization of sepsis diagnostics techniques is expected to witness a significant rise with increase in disease diagnosis. The sepsis diagnostics market has piqued the interest of the healthcare industry, owing to its high accuracy and precise techniques
The CXOs further added that there have been remarkable advancements and some major developments in this market, such as devices with more throughput and accurate results. Owing to increase in chronic & infectious diseases, use of automated instruments, and rise in awareness regarding healthcare, North America is expected to emerge as a prominent leader in the global sepsis diagnostics market.
According to the perspectives of CXOs of leading companies in the market, rise in prevalence of infectious diseases, increase in cases of hospital-acquired infections, and technological advancements are some of the major factors that drive the growth of the global sepsis diagnostics market. However, high cost of automated diagnostic devices hampers the market growth.
As stated by CXOs, an increase in the incidence of chronic and infectious diseases boosts the demand for sepsis diagnostics techniques, as they are the simplest technique for diagnosis of diseases. Therefore, use of sepsis diagnostics techniques, such as molecular diagnostics, point-of-care testing, and immunodiagnostics, in standalone laboratories and hospitals is expected to fuel the market growth in the future.
In addition, the employment of sepsis diagnostics techniques is highest in North America, owing to increase in use of automated instruments, followed by Europe and Asia-Pacific. Furthermore, use of minimally invasive techniques is expected to boost the growth of the in vitro diagnostics market in Europe and Asia-Pacific.
A. The upcoming trends of Global Sepsis Diagnostic Market in the world includes increase in government funding for sepsis-related research activities and rise in prevalence of infectious disease further drive the market growth
A. The leading application of Global Sepsis Diagnostic Market includes Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry
A. North America is the largest regional market for Global Sepsis Diagnostic.
A. Global Sepsis Diagnostic is projected to reach $1207.58 million by 2030, registering a CAGR of 7.8% from 2021 to 2030.
A. The top companies to hold the market share in Global Sepsis Diagnostic includes BioMerieux, Thermo Fisher Scientific Inc., Abbott Laboratories, Inc., Becton, Dickinson and Company, Bruker Corporation, Beckman Coulter, Inc., T2 Biosystems, Inc., Nanosphere, Inc., Hoffmann-LA Roche Ltd., Danaher Corporation.
Start reading instantly.
This Report and over 67,069+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers